Nuvation Bio Inc. (NUVB) Earnings History
Annual and quarterly earnings data from 2018 to 2025
Loading earnings history...
NUVB EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
NUVB Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 86.6% | -338.7% | -325.3% |
| 2024 | 10.1% | -7527.3% | -7213.8% |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
Download Data
Export NUVB earnings history in CSV or JSON format
Free sign-in required to download data
Nuvation Bio Inc. (NUVB) Earnings Overview
As of May 8, 2026, Nuvation Bio Inc. (NUVB) reported trailing twelve-month net income of -$146M, reflecting +71.6% year-over-year growth. The company earned $-0.39 per diluted share over the past four quarters, with a net profit margin of -325.3%.
Looking at the long-term picture, NUVB's historical earnings data spans multiple years. The company achieved its highest annual net income of -$992,000 in fiscal 2018.
Nuvation Bio Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including KYMR (-$315M net income, -794.4% margin), TPST (-$36M net income), PRAX (-$327M net income), NUVB has outperformed on profitability metrics. Compare NUVB vs KYMR →
NUVB Earnings vs Peers
Earnings metrics vs comparable public companies
NUVB Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$205M | +64.0% | -$213M | $-0.60 | -325.3% | -338.7% |
| 2024 | -$568M | -649.2% | -$593M | $-2.11 | -7213.8% | -7527.3% |
| 2023 | -$76M | +27.3% | -$100M | $-0.35 | - | - |
| 2022 | -$104M | -20.0% | -$120M | $-0.48 | - | - |
| 2021 | -$87M | -108.5% | -$93M | $-0.44 | - | - |
| 2020 | -$42M | -24.2% | -$44M | $-0.19 | - | - |
| 2019 | -$34M | -3282.3% | -$32M | $-0.16 | - | - |
| 2018 | $-992,000 | - | $-992,000 | $-0.01 | - | - |
See NUVB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NUVB Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NUVB vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNUVB — Frequently Asked Questions
Quick answers to the most common questions about buying NUVB stock.
Is NUVB growing earnings?
NUVB EPS is $-0.39, with earnings growth accelerating to +71.6%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-146M.
What are NUVB's profit margins?
Nuvation Bio Inc. net margin is -325.3%, with operating margin at -338.7%. Below-average margins reflect competitive or cost pressures.
How consistent are NUVB's earnings?
NUVB earnings data spans 2018-2025. The accelerating earnings trend is +71.6% YoY. Historical data enables comparison across business cycles.